在药物辅助治疗中患有阿片类药物使用障碍的妇女中隐含偏见和母乳养
Chelsea Horn1, Katherine M Newnam
1Author Affiliations: College of Nursing, University of Tennessee, Knoxville.
概括
医疗保健提供者的隐性偏见对患有阿片类药物使用障碍 (OUD) 的母亲的母乳养支持产生负面影响. 在基于证据的实践上教育提供者可以减少偏见,并改善这些母亲及其新生儿的护理.
科学领域:
- 母婴健康 母婴健康 新生儿健康
- 医疗保健提供者的偏见
- 药物使用障碍治疗 药物使用障碍治疗
背景情况:
- 建议在药物辅助治疗 (MAT) 期间对患有阿片类药物使用障碍 (OUD) 的母亲进行母乳养.
- 医疗保健提供者的隐性偏见可能会对OUD的母亲的护理质量和母乳养结果产生负面影响.
- 对患有OUD的母亲来说,关于母乳养的决策是复杂的.
研究的目的:
- 综合证据,了解医疗保健专业人员的隐性偏见如何影响OUD妇女的母乳养.
- 确定对母乳养启动,支持和延续的影响.
主要方法:
- 综合性综述关于女性OUD对MAT和母乳养的研究.
- 纳入标准侧重于与母乳养有关的偏见.
- 排除了不涉及孕妇/产后妇女接受MAT或仅基于种族偏见的研究.
主要成果:
- 关键主题包括耻辱,歧视和缺乏支持.
- 确定了提供者知识缺口和母亲的康复恐惧.
- 包括定性,定量和混合方法研究.
结论:
- 教育医疗保健提供者可以减少偏见,并改善对患有OUD的母乳养母亲的支持.
- 需要进一步研究隐性偏见的影响,以告知培训和资源.
- 解决提供者偏见对于支持母婴结合和婴儿营养至关重要.
相关概念视频
Analgesia and Pain Management
2.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.5K
Drug Dosing: Obese Patients
320
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
320
Bias in Epidemiological Studies
1.5K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.5K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.3K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
331
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
331
Drug Abuse and Addiction: Pharmacological Phenomena
1.4K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.4K


